Firms

Birchview Capital

Birchview Capital

Boston, Massachusetts, United States · Burlington, Vermont, United States

Birchview Capital LP is a Massachusetts and Vermont healthcare investment manager, combining medical and life-science diligence with quantitative research, AI, natural-language processing and machine learning. The firm invests in public and private healthcare companies intended to address unmet clinical needs, and manages private funds and separately managed accounts. Its current public team spans healthcare investing, quantitative strategies, investment operations and finance. The firm began operations in 2014 and has offices in Boston and Burlington. Birchview’s neuroscience exposure includes equity investment in Monteris Medical, developing minimally invasive brain surgery technology. It is a distinct US investment adviser from the unrelated Ontario acquisition firm at birchviewcapital.ca. Regulatory assets under management and public securities portfolio values are not fund-closing amounts.

Founded
2014
Type
Venture capital

Funds13

  • BIRCHVIEW CAPITAL VF III, LLC—

    Legal private-fund vehicle disclosed by Birchview Capital LP in its March 31, 2026 Form ADV. This is a named vehicle, including single-investment holding entities, rather than an additional independently sized flagship fund. No verified final closed capital total or closing announcement date was found; regulatory gross asset value is not a fundraising amount.

  • BIRCHVIEW FUND LLC—

    Legal private-fund vehicle disclosed by Birchview Capital LP in its March 31, 2026 Form ADV. This is a named vehicle, including single-investment holding entities, rather than an additional independently sized flagship fund. No verified final closed capital total or closing announcement date was found; regulatory gross asset value is not a fundraising amount. Its January 2019 amended Form D reported cumulative subscriptions in an indefinite offering that began in March 2014; those cumulative proceeds are not treated as a final fund-closing size.

  • Birchview SB-68 Healthcare Fund LLC—

    Delaware healthcare hedge-fund vehicle formed in 2026, with Birchview Capital LP identified as investment manager. Its June 26, 2026 Form D described an indefinite offering, first sale yet to occur, zero proceeds and zero investors. No fundraising close or closed amount is asserted.

  • ED BC HOLDINGS 3, LLC—

    Legal private-fund vehicle disclosed by Birchview Capital LP in its March 31, 2026 Form ADV. This is a named vehicle, including single-investment holding entities, rather than an additional independently sized flagship fund. No verified final closed capital total or closing announcement date was found; regulatory gross asset value is not a fundraising amount.

  • ED BC HOLDINGS LLC—

    Legal private-fund vehicle disclosed by Birchview Capital LP in its March 31, 2026 Form ADV. This is a named vehicle, including single-investment holding entities, rather than an additional independently sized flagship fund. No verified final closed capital total or closing announcement date was found; regulatory gross asset value is not a fundraising amount.

  • MONTERIS BC HOLDINGS 2, LLC—

    Legal private-fund vehicle disclosed by Birchview Capital LP in its March 31, 2026 Form ADV. This is a named vehicle, including single-investment holding entities, rather than an additional independently sized flagship fund. No verified final closed capital total or closing announcement date was found; regulatory gross asset value is not a fundraising amount.

  • MONTERIS BC HOLDINGS 3, LLC—

    Legal private-fund vehicle disclosed by Birchview Capital LP in its March 31, 2026 Form ADV. This is a named vehicle, including single-investment holding entities, rather than an additional independently sized flagship fund. No verified final closed capital total or closing announcement date was found; regulatory gross asset value is not a fundraising amount.

  • MONTERIS BC HOLDINGS 4 LLC—

    Legal private-fund vehicle disclosed by Birchview Capital LP in its March 31, 2026 Form ADV. This is a named vehicle, including single-investment holding entities, rather than an additional independently sized flagship fund. No verified final closed capital total or closing announcement date was found; regulatory gross asset value is not a fundraising amount.

Team

Operations and support

Ben SmallChief Operating Officer
Jack TrottierChief Financial and Compliance Officer
Matthew StrobeckMatthew StrobeckManaging Partner
Nicholas RenegarDirector of Quantitative Strategies

Co-investing

Investments